Patents by Inventor Douglas Byron Sherman

Douglas Byron Sherman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150004629
    Abstract: The present invention relates to functional, modified glucose-galactose binding proteins (GGBPs), that have a greater melting temperature (Tm) than a reference GGBP. The present invention also relates to biological sensors, e.g., glucose sensors, comprising these thermostable GGBPs. The present invention also relates to nucleic acids encoding these thermostable GGBPs.
    Type: Application
    Filed: June 6, 2014
    Publication date: January 1, 2015
    Applicant: Becton, Dickinson and Company
    Inventors: Terry J. Amiss, Erin M. Gill, Douglas Byron Sherman
  • Patent number: 8778635
    Abstract: The present invention relates to functional, modified glucose-galactose binding proteins (GGBPs), that have a greater melting temperature (Tm) than a reference GGBP. The present invention also relates to biological sensors, e.g., glucose sensors, comprising these thermostable GGBPs. The present invention also relates to nucleic acids encoding these thermostable GGBPs.
    Type: Grant
    Filed: July 24, 2013
    Date of Patent: July 15, 2014
    Assignee: Becton, Dickinson and Company
    Inventors: Terry J. Amiss, Erin M. Gill, Douglas Byron Sherman
  • Publication number: 20130302908
    Abstract: The present invention relates to functional, modified glucose-galactose binding proteins (GGBPs), that have a greater melting temperature (Tm) than a reference GGBP. The present invention also relates to biological sensors, e.g., glucose sensors, comprising these thermostable GGBPs. The present invention also relates to nucleic acids encoding these thermostable GGBPs.
    Type: Application
    Filed: July 24, 2013
    Publication date: November 14, 2013
    Inventors: Terry J. Amiss, Erin M. Gill, Douglas Byron Sherman
  • Patent number: 6235717
    Abstract: The present invention provides a compound of formula (I) or a salt thereof as well as methods of making and using same.
    Type: Grant
    Filed: July 3, 1995
    Date of Patent: May 22, 2001
    Assignee: Glaxo Wellcome Inc.
    Inventors: Johann Jakob Leban, Douglas Byron Sherman, James Frederick Sigafoos, Andreas Spaltenstein, Osvaldo Humberto Viveros, David Chi-cheong Wan